Clinical Trials Browser

Phase 2/3 × Breast Diseases × Goserelin × Clear all

NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Phase 2/3 Unknown

Breast Diseases, Breast Neoplasms